drugset / Trial / NCT04408937

The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor.

NCT04408937

Phase 1 Completed 89 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether dosing tropifexor is safe and tolerable.

Timeline

Start
2020-05-29
Primary completion
2020-11-04
Completion
2020-11-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Tropifexor Small molecule 200 ug Oral

Indications